Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest for painful symptoms in Chinese patients with adenomyosis
ChiCTR2000039040Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dienogest in adenomyosis, sponsored by Qilu Hospital of Shandong University. Primary endpoint: Pain. Started Nov 2020; status: recruiting.
02
Drugs
dienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2000039040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039040.